In total , 157 of 256 patients randomized to esomeprazole 20mg once daily remained on this dose until the end of follow-up or study discontinuation , whereas 99 patients had their dose increased because of inadequate symptom control ( of these , 29 subsequently returned to the allocated dose ) .